INTERNATIONAL PATENT: BRIDGE BIOTHERAPEUTICS, INC., 브릿지바이오테라퓨틱스(주) FILES APPLICATION FOR "PHARMACEUTICAL COMPOSITION COMPRISING AUTOTAXIN INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CALCIFICATION-RELATED DISEASE"

GENEVA, Dec. 16 -- BRIDGE BIOTHERAPEUTICS, INC. (303-ho, 58 Pangyo-ro 255beon-gil,Bundang-gu, Seongnam-si,Gyeonggi-do 13486), 브릿지바이오테라퓨틱스(주) (경기도성남시 분당구판교로 255번길 58, 303호) filed a patent application (PCT/KR2025/001990) for "PHARMACEUTICAL COMPOSITION COMPRISING AUTOTAXIN INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CALCIFICATION-RELATED DISEASE" on Feb 11, 2025. With publication no. WO/2025/254295, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the Internationa...